Enanta Pharmaceuticals (ENTA) Amortization of Deferred Charges (2013 - 2015)
Enanta Pharmaceuticals posted quarterly Amortization of Deferred Charges of $2000.0 for Q2 2015, down 60.0% year-on-year from $5000.0 in Q2 2014, and little changed on a QoQ basis from $2000.0 in Q1 2015.
Enanta Pharmaceuticals (ENTA) has 3 years of Amortization of Deferred Charges data on file, last reported at $2000.0 in Q2 2015.
- For the quarter ending Q2 2015, Amortization of Deferred Charges fell 60.0% year-over-year to $2000.0; the trailing twelve-month figure through Mar 2015 stood at $3000.0 (down 87.5% YoY), and the FY2014 full-year result was $8000.0, down 74.19% from the prior year.
- Amortization of Deferred Charges for Q2 2015 stood at $2000.0, roughly flat from $2000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $8000.0 in Q3 2013 and bottomed at -$6000.0 in Q3 2014.
- The 3-year median for Amortization of Deferred Charges is $4000.0 (2014), against an average of $3222.2.
- Peak annual rise in Amortization of Deferred Charges reached 28.57% in 2014, while the deepest fall reached 175.0% in 2014.
- A 3-year view of Amortization of Deferred Charges shows it stood at $5000.0 in 2013, then sank by 60.0% to $2000.0 in 2014, then changed by 0.0% to $2000.0 in 2015.
- The last three Amortization of Deferred Charges figures came in at $2000.0 (Q2 2015), $2000.0 (Q1 2015), and $2000.0 (Q4 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 2,000.00 |
| Jun 30, 2015 | 2,000.00 |
| Mar 31, 2015 | 2,000.00 |
| Mar 31, 2015 | 2,000.00 |
| Dec 31, 2014 | 2,000.00 |
| Dec 31, 2014 | 2,000.00 |
| Sep 30, 2014 | -6,000.00 |
| Sep 30, 2014 | -6,000.00 |
| Jun 30, 2014 | 5,000.00 |
| Jun 30, 2014 | 5,000.00 |
| Mar 31, 2014 | 4,000.00 |
| Mar 31, 2014 | 4,000.00 |
| Dec 31, 2013 | 5,000.00 |
| Dec 31, 2013 | 5,000.00 |
| Sep 30, 2013 | 8,000.00 |
| Sep 30, 2013 | 8,000.00 |
| Jun 30, 2013 | 7,000.00 |
| Jun 30, 2013 | 7,000.00 |